Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging.

Eby NS, Griffith JL, Gutmann DH, Morris SM.

Dev Med Child Neurol. 2019 Aug;61(8):972-978. doi: 10.1111/dmcn.14144. Epub 2019 Jan 18.

PMID:
30659594
2.

Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?

Payne JM, Arnold SS, Pride NA, North KN.

Dev Med Child Neurol. 2012 Oct;54(10):898-904. doi: 10.1111/j.1469-8749.2012.04357.x. Epub 2012 Jul 28.

3.

Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?

Roy A, Barbarot S, Charbonnier V, Gayet-Delacroix M, Stalder JF, Roulin JL, Le Gall D.

Neuropsychology. 2015 May;29(3):473-84. doi: 10.1037/neu0000151. Epub 2014 Nov 3.

PMID:
25365565
4.

Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.

Parmeggiani A, Boiani F, Capponi S, Duca M, Angotti M, Pignataro V, Sacrato L, Spinardi L, Vara G, Maltoni L, Cecconi I, Pastore Trossello M, Franzoni E.

Eur J Paediatr Neurol. 2018 Sep;22(5):822-830. doi: 10.1016/j.ejpn.2018.04.016. Epub 2018 May 4.

PMID:
29802023
5.

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

Walsh KS, Vélez JI, Kardel PG, Imas DM, Muenke M, Packer RJ, Castellanos FX, Acosta MT.

Dev Med Child Neurol. 2013 Feb;55(2):131-8. doi: 10.1111/dmcn.12038. Epub 2012 Nov 16.

6.

Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.

Descheemaeker MJ, Plasschaert E, Frijns JP, Legius E.

J Intellect Disabil Res. 2013 Sep;57(9):874-86. doi: 10.1111/j.1365-2788.2012.01648.x. Epub 2012 Oct 24.

PMID:
23095048
7.

Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.

Ribeiro MJ, Violante IR, Bernardino I, Edden RA, Castelo-Branco M.

Cortex. 2015 Mar;64:194-208. doi: 10.1016/j.cortex.2014.10.019. Epub 2014 Nov 11.

8.

Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I.

Loitfelder M, Huijbregts SC, Veer IM, Swaab HS, Van Buchem MA, Schmidt R, Rombouts SA.

Brain Connect. 2015 Jun;5(5):312-20. doi: 10.1089/brain.2014.0334. Epub 2015 Mar 31.

9.

Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior.

Payne JM, Hyman SL, Shores EA, North KN.

Child Neuropsychol. 2011;17(4):313-29. doi: 10.1080/09297049.2010.542746.

PMID:
21347908
10.

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

Hyman SL, Shores A, North KN.

Neurology. 2005 Oct 11;65(7):1037-44.

PMID:
16217056
11.

Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.

van der Vaart T, Rietman AB, Plasschaert E, Legius E, Elgersma Y, Moll HA; NF1-SIMCODA Study Group.

Neurology. 2016 Jan 12;86(2):154-60. doi: 10.1212/WNL.0000000000002118. Epub 2015 Oct 30.

12.

Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?

Rüegger AD, Coleman L, Hansford JR, McLean N, Dabscheck G.

Pediatr Neurol. 2018 Sep;86:63-65. doi: 10.1016/j.pediatrneurol.2018.07.005. Epub 2018 Jul 20.

PMID:
30174245
13.
14.

Social functioning in adults with neurofibromatosis type 1.

Pride NA, Crawford H, Payne JM, North KN.

Res Dev Disabil. 2013 Oct;34(10):3393-9. doi: 10.1016/j.ridd.2013.07.011. Epub 2013 Aug 2.

PMID:
23911645
15.

White matter microstructure of patients with neurofibromatosis type 1 and its relation to inhibitory control.

Koini M, Rombouts SARB, Veer IM, Van Buchem MA, Huijbregts SCJ.

Brain Imaging Behav. 2017 Dec;11(6):1731-1740. doi: 10.1007/s11682-016-9641-3.

16.

T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.

Hyman SL, Gill DS, Shores EA, Steinberg A, North KN.

J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1088-91. Epub 2007 Feb 13.

17.

Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence.

Lehtonen A, Howie E, Trump D, Huson SM.

Dev Med Child Neurol. 2013 Feb;55(2):111-25. doi: 10.1111/j.1469-8749.2012.04399.x. Epub 2012 Aug 31. Review.

18.

A neuropsychological perspective on attention problems in neurofibromatosis type 1.

Templer AK, Titus JB, Gutmann DH.

J Atten Disord. 2013 Aug;17(6):489-96. doi: 10.1177/1087054711433422. Epub 2012 Feb 21. Review.

PMID:
22354384
19.

The Key Search Subtest of the Behavioural Assessment of the Dysexecutive Syndrome in Children (BADS-C) Instrument Reveals Impaired Planning Without External Constraints in Children With Neurofibromatosis Type 1.

Riva D, Vago C, Erbetta A, Saletti V, Esposito S, Micheli R, Bulgheroni S.

J Child Neurol. 2017 Mar;32(4):387-396. doi: 10.1177/0883073816683322. Epub 2016 Dec 20.

PMID:
28193119
20.

The impact of ADHD on the cognitive and academic functioning of children with NF1.

Pride NA, Payne JM, North KN.

Dev Neuropsychol. 2012;37(7):590-600. doi: 10.1080/87565641.2012.695831.

PMID:
23066937

Supplemental Content

Support Center